Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Nyxoah SA (NYXH) vs Utah Medical Products, Inc. (UTMD)

Nyxoah SA and Utah Medical Products, Inc. are both Medical Instruments & Supplies companies. Utah Medical Products, Inc. is the larger, with a market value of $238.0M against $129.3M — 1.8× the size. Nyxoah SA has negative trailing earnings, so its P/E is not meaningful; Utah Medical Products, Inc. trades at 22.7×. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against −7.00%. Utah Medical Products, Inc. has the higher net margin (29.0% vs −446.4%) and the higher return on invested capital (18.6% vs −117.8%). Across the 19 metrics below, Utah Medical Products, Inc. leads on 13 and Nyxoah SA on 6.

Valuation

Metric NYXH UTMD Medical Instruments & Supplies median
P/E n/m 22.69 34.17
P/S 3.30 6.56 2.83
P/B 0.86 1.94 2.82
Price to free cash flow n/m 20.70 25.69
EV/EBITDA n/m 11.82 16.08
EV/Sales 1.52 4.17 3.06
Earnings yield (173.79%) 4.41% (1.84%)
Free cash flow yield (104.64%) 4.83% 0.17%

Profitability

Metric NYXH UTMD Medical Instruments & Supplies median
Gross margin 60.16% 57.90% 54.62%
Operating margin (391.25%) 28.43% 1.64%
Net margin (446.39%) 29.04% 0.00%
Free cash flow margin (344.99%) 31.70% 1.61%
Return on equity (124.41%) 8.75% 0.00%
Return on assets (68.23%) 8.55% 0.00%
Return on invested capital (117.82%) 18.60% 0.00%

Growth

Metric NYXH UTMD Medical Instruments & Supplies median
Revenue growth (TTM) 366.24% (7.00%) 9.20%
EPS growth (last fiscal year) (36.22%) (12.12%) —
Revenue growth, 5-year CAGR 170.14% (1.80%) 9.48%
Net income growth, 5-year CAGR 0.00% 0.89% 0.00%

Health

Metric NYXH UTMD Medical Instruments & Supplies median
Debt to equity 0.72 0.00 0.08
Current ratio 2.38 48.62 2.49
Net debt to EBITDA 0.08 (5.95) 0.83

Dividend

Metric NYXH UTMD Medical Instruments & Supplies median
Dividend yield — 1.60% 0.99%
Payout ratio 0.00 0.25 0.00

Size

Metric NYXH UTMD Medical Instruments & Supplies median
Market cap 129.34m 237.99m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack